CRISPR takes a bold leap toward silencing Down syndrome's extra chromosome

Researchers are using CRISPR technology to target the extra chromosome associated with Down syndrome, marking a significant advancement in genetic therapy. This breakthrough could potentially lead to new treatments for the condition.